CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract] Total current assets TOTAL ASSETS Total assets Total current liabilities TOTAL LIABILITIES TOTAL STOCKHOLDERS' EQUITY Balance Balance TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] Gross profit Total operating expenses INCOME FROM OPERATIONS Other income (expense), net Other income (expense), net INCOME BEFORE INCOME TAXES Income (loss) before taxes NET INCOME Net income CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY [Abstract] Balance (in Shares) Balance (in Shares) Balance, Treasury stock (in Shares) Balance, Treasury stock (in Shares) Treasury stock (in Shares) Equity Components [Axis] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] Net cash provided by operating activities Net cash provided by (used in) investing activities Debt Instrument [Axis] Net cash used in financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period ORGANIZATION AND BUSINESS [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] Antidilutive Securities [Axis] INVENTORIES [Abstract] Total inventories, net Inventories, net PROPERTY AND EQUIPMENT [Abstract] Long-Lived Asset, Class [Axis] Total property and equipment, net Property and equipment, net ASSETS AND LIABILITIES HELD FOR SALE [Abstract] ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES [Abstract] Total accrued expenses and other current liabilities Accrued expenses and other current liabilities DEBT [Abstract] Credit Facility [Axis] Total debt Total debt Line of Credit Facility, Maximum Amount (in Dollars) STOCKHOLDERS’ EQUITY [Abstract] Statistical Measurement [Axis] Award Type [Axis] Options outstanding, vested and expected to vest, beginning balance Options outstanding, vested and expected to vest, ending balance Options outstanding, vested and expected to vest, beginning balance - Weighted average exercise price Options outstanding, vested and expected to vest, ending balance - Weighted average exercise price Beginning balance Ending balance Beginning balance - Weighted average grant date fair value Ending balance - Weighted average grant date fair value RELATED PARTY TRANSACTIONS [Abstract] COMMITMENTS AND CONTINGENCIES [Abstract] SEGMENTS [Abstract] Consolidation Items [Axis] Segments [Axis] Geographical [Axis] Product and Service [Axis] LEASE OBLIGATIONS [Abstract] Total payments INCOME TAXES [Abstract] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION [Abstract] Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Amendment Flag Document Fiscal Period Focus Current Fiscal Year End Date ASSETS Current assets: Cash and cash equivalents Accounts receivable, net Prepaid expenses and other current assets Assets held for sale Intangible assets, net Goodwill Deferred tax assets, net Right-of-use assets Deposits and other assets LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Current portion of long-term debt Less: current portion of long-term debt Current portion of lease obligations Current portion Liabilities held for sale Long-term debt Deferred revenue, net of current portion Lease obligations, net of current portion Balance at June 30, 2026 COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITY Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized (in Shares) Preferred stock, shares issued (in Shares) Preferred stock, shares outstanding (in Shares) Preferred stock, outstanding (in Shares) Common Stock - voting, $0.0001 par value, 300,000,000 shares authorized, June 30, 2026: 241,089,992 issued and 225,355,228 outstanding; December 31, 2025: 239,793,566 issued and 237,874,496 outstanding Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares outstanding (in Shares) Common stock, shares issued (in Shares) Additional paid-in capital Accumulated deficit REVENUES Revenues Cost of product revenue OPERATING EXPENSES: Research and development Plasma center operating expenses Amortization of intangible assets Selling, general and administrative Consolidated selling, general and administrative expense OTHER INCOME (EXPENSE): Interest and other income Loss on extinguishment of debt Loss on extinguishment of debt Other expense Provision for income taxes BASIC EARNINGS PER COMMON SHARE (in Dollars per share) Basic earnings per common share (in Dollars per share) DILUTED EARNINGS PER COMMON SHARE (in Dollars per share) Diluted earnings per common share (in Dollars per share) WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic (in Shares) Weighted-average number of common shares (denominator) Diluted (in Shares) Total shares - diluted (denominator) Stock-based compensation Cashless exercise of warrants Cashless exercise of warrants (in Shares) Vesting of Restricted Stock Units, net of shares withheld for taxes Vesting of Restricted Stock Units, net of shares withheld for taxes (in Shares) Exercise of stock options Exercise of stock options (in Shares) CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization Depreciation and amortization expense Deferred income tax provision Stock-based compensation Stock-based compensation expense Plasma center operating expenses Amortization of debt discount Amortization of license revenue Changes in operating assets and liabilities: Accounts payable Accrued expenses Other current and non-current liabilities CASH FLOWS FROM INVESTING ACTIVITIES: Proceeds on the sales of assets held for sale CASH FLOWS FROM FINANCING ACTIVITIES: Revolving facility proceeds Amount borrowed under credit facility (in Dollars) Net proceeds from the exercise of stock options Treasury stock, at cost, 15,734,764 and 1,919,070 shares as of June 30, 2026 and December 31, 2025, respectively Gain on sale of plasma centers Gain on sale of plasma centers Interest expense Unallocated interest expense, primarily related to interest on senior debt (see Note 6) Acquisition of treasury stock Total cost of shares repurchased Acquisition of treasury stock (in Shares) Shares repurchased (in Shares) Loss on disposal of fixed assets Accounts receivable Inventories Prepaid expenses and other current assets Deposits and other assets Purchase of property and equipment Acquisition of intangible assets Term loan payments Prepayment penalties on repayment of debt Taxes paid on vested restricted stock units Payment of end of term fee Acquisition of treasury stock Common Stock [Member]